Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 1, Pages 87
Publisher
MDPI AG
Online
2021-12-22
DOI
10.3390/ijms23010087
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD27 enhances the killing effect of CAR T cells targeting trophoblast cell surface antigen 2 in the treatment of solid tumors
- (2021) Huanpeng Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
- (2021) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
- (2021) A. Bardia et al. ANNALS OF ONCOLOGY
- Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review
- (2021) Vittoria Perrotti et al. Cancers
- Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation
- (2020) Baoping Zhang et al. BMC CANCER
- Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway
- (2020) Annie Wai Yeeng Chai et al. eLife
- The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients
- (2020) Gerrit Spanier et al. CANCER LETTERS
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
- (2019) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-Drug Conjugate-Based Therapeutics: State of the Science
- (2019) Michael J Birrer et al. JNCI-Journal of the National Cancer Institute
- TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway
- (2019) Genxiong Tang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Progress in targeted therapeutic drugs for oral squamous cell carcinoma
- (2019) Lian Liu et al. SURGICAL ONCOLOGY-OXFORD
- Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition
- (2018) Ján Remšík et al. CARCINOGENESIS
- Trop2 is a potential biomarker for the promotion of EMT in human breast cancer
- (2018) Wei Zhao et al. ONCOLOGY REPORTS
- The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
- (2018) David M. Goldenberg et al. Oncotarget
- High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma
- (2018) Genxiong Tang et al. PATHOLOGY RESEARCH AND PRACTICE
- TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells
- (2016) Zanhua Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis
- (2016) Ping Zeng et al. Scientific Reports
- First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
- (2015) A. N. Starodub et al. CLINICAL CANCER RESEARCH
- Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2
- (2015) Fabian B. Fahlbusch et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
- (2015) David M. Goldenberg et al. Oncotarget
- Trop-2 Is a Determinant of Breast Cancer Survival
- (2014) Federico Ambrogi et al. PLoS One
- Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis
- (2014) F Wang et al. Cell Death & Disease
- Trop-2 Promotes Prostate Cancer Metastasis By Modulating 1 Integrin Functions
- (2013) M. Trerotola et al. CANCER RESEARCH
- The clinical significance of SWI/SNF complex in pancreatic cancer
- (2012) MASAKATSU NUMATA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues
- (2011) Lara P. Stepan et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma
- (2011) J. Wang et al. MOLECULAR CANCER RESEARCH
- Global epidemiology of oral and oropharyngeal cancer
- (2008) Saman Warnakulasuriya ORAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started